Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Arunachalam

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Science Translational Medicine|January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine responseSaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Science Translational Medicine|August 17, 2022
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccinePrabhu S Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Cell|October 7, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Alexandra Schäfer, et al.
Nature|April 19, 2021
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Science Translational Medicine|January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine responseSaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Science Translational Medicine|August 17, 2022
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccinePrabhu S Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Cell|October 7, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Alexandra Schäfer, et al.
Nature|April 19, 2021
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Pageof 8